Cargando…

Efficacy and Safety of Belatacept Treatment in Renal Allograft Recipients at High Cardiovascular Risk—A Single Center Experience

Belatacept is an attractive option for immunosuppression after renal transplantation. Renal allograft function is superior when compared to calcineurin inhibitor (CNI) based therapy in “de novo” treated patients and it has also been proposed that individuals at high cardiovascular (CV) risk may bene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neuwirt, Hannes, Leitner-Lechner, Irmgard, Kerschbaum, Julia, Ertl, Michael, Pöggsteiner, Florian, Pölt, Nicolas, Mätzler, Julius, Sprenger-Mähr, Hannelore, Rudnicki, Michael, Schratzberger, Peter, Eder, Iris E., Mayer, Gert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723198/ https://www.ncbi.nlm.nih.gov/pubmed/31382583 http://dx.doi.org/10.3390/jcm8081164

Ejemplares similares

Arterial Hypertension as a Risk Factor for Reduced Glomerular Filtration Rate after Living Kidney Donation
por: Kerschbaum, Julia, et al.
Publicado: (2020)

A 3-biomarker-panel predicts renal outcome in patients with proteinuric renal diseases
por: Neuwirt, Hannes, et al.
Publicado: (2014)

In Reply to ‘Do SGLT-2 Inhibitors Act Only Through a Functional Tubuloglomerular Feedback Induced by the Increased Outflow of Sodium?’
por: Neuwirt, Hannes, et al.
Publicado: (2020)

Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease
por: Leierer, Johannes, et al.
Publicado: (2021)

Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients – a pilot study
por: Bremer, Sara, et al.
Publicado: (2009)

Increased Renal Versican Expression Is Associated with Progression of Chronic Kidney Disease
por: Rudnicki, Michael, et al.
Publicado: (2012)

Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study
por: Osmanodja, Bilgin, et al.
Publicado: (2023)

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients
por: van der Zwan, Marieke, et al.
Publicado: (2018)

Long-Term Treatment with Simvastatin Leads to Reduced Migration Capacity of Prostate Cancer Cells
por: Kafka, Mona, et al.
Publicado: (2022)

Intra-individual variability of eGFR trajectories in early diabetic kidney disease and lack of performance of prognostic biomarkers
por: Kerschbaum, Julia, et al.
Publicado: (2020)

Belatacept: Good, but not good enough?
por: Parameswaran, Sreejith, et al.
Publicado: (2012)

Belatacept: the challenges with transformational drugs
por: Vincenti, Flavio
Publicado: (2017)

Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency
por: Zitt, Emanuel, et al.
Publicado: (2015)

Belatacept and mediastinal histoplasmosis in a kidney transplant patient
por: Trimarchi, Hernán, et al.
Publicado: (2016)

Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens
por: Ashokkumar, Chethan, et al.
Publicado: (2015)

Impact of Timely Public Health Measures on Kidney Transplantation in Austria during the SARS-CoV-2 Outbreak—A Nationwide Analysis
por: Watschinger, Bruno, et al.
Publicado: (2020)

Conversion from tacrolimus to belatacept improves renal function in kidney transplant patients with chronic vascular lesions in allograft biopsy
por: Pérez-Sáez, María José, et al.
Publicado: (2018)

Antibody Response to mRNA Vaccines against SARS-CoV-2 with Chronic Kidney Disease, Hemodialysis, and after Kidney Transplantation
por: Buchwinkler, Lukas, et al.
Publicado: (2021)

Humoral Immune Response to a Timely Booster mRNA Vaccination in Non-Responders to a Standard Vaccination Schedule against COVID-19 in Kidney Transplant Recipients
por: Stigler, Julia, et al.
Publicado: (2022)

Acute Kidney Injury Treated with Dialysis outside the Intensive Care Unit: A Retrospective Observational Single-Center Study
por: Sprenger-Mähr, Hannelore, et al.
Publicado: (2016)

Tubuloglomerular Feedback in Renal Glucosuria: Mimicking Long-term SGLT-2 Inhibitor Therapy
por: Neuwirt, Hannes, et al.
Publicado: (2019)

Belatacept: A worthy alternative to cyclosporine?
por: Melvin, George, et al.
Publicado: (2012)

Belatacept for Maintenance Immunosuppression in Lung Transplantation
por: Hui, Christine, et al.
Publicado: (2014)

Belatacept in renal transplantation—quo vadis?
por: Westhoff, Timm H.
Publicado: (2016)

Computational Drug Screening Identifies Compounds Targeting Renal Age-associated Molecular Profiles
por: Koppelstaetter, Christian, et al.
Publicado: (2019)

A Case of Pneumocystis jirovecii Pneumonia under Belatacept and Everolimus: Benefit-Risk Balance between Renal Allograft Function and Infection
por: Perrier, Quentin, et al.
Publicado: (2021)

What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern
por: Gauckler, Philipp, et al.
Publicado: (2021)

Belatacept Conversion in Kidney After Liver Transplantation
por: Cristea, Octav, et al.
Publicado: (2021)

A case of belatacept-induced chilblain lupus
por: Kinariwalla, Neha, et al.
Publicado: (2022)

A Mixed-chimerism Protocol Utilizing Thymoglobulin and Belatacept Did Not Induce Lung Allograft Tolerance, Despite Previous Success in Renal Allotransplantation
por: Sommer, Wiebke, et al.
Publicado: (2021)

Successful Treatment of Focal Segmental Glomerulosclerosis after Kidney Transplantation with Plasma Exchange and Abatacept in a Patient with Juvenile Rheumatoid Arthritis
por: Sprenger-Mähr, Hannelore, et al.
Publicado: (2016)

Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid Culture
por: Eder, Theresa, et al.
Publicado: (2016)

Is There Decreasing Public Interest in Renal Transplantation? A Google Trends(TM) Analysis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Abstract: Belatacept and Rapamycin with Short-Term Use of Tacrolimus Delay Allograft Rejection in a Novel, Large Animal Vascularized Composite Allotransplantation Model
por: Elgendy, Tarek, et al.
Publicado: (2018)

CD28 Family and Chronic Rejection: “To Belatacept...and Beyond!”
por: Silva, Marcos V., et al.
Publicado: (2012)

Belatacept in kidney transplant patients with systemic lupus erythematosus
por: Carrión-Barberà, Irene, et al.
Publicado: (2019)

Time-Limited Therapy with Belatacept in Kidney Transplant Recipients
por: Letellier, Thibault, et al.
Publicado: (2022)

Succinate Accumulation Is Associated with a Shift of Mitochondrial Respiratory Control and HIF-1α Upregulation in PTEN Negative Prostate Cancer Cells
por: Weber, Anja, et al.
Publicado: (2018)

Risk Factors Associated with Peritoneal-Dialysis-Related Peritonitis
por: Kerschbaum, Julia, et al.
Publicado: (2012)

Treatment of Concurrent Thrombotic Thrombocytopenic Purpura and Graves' Disease: A Report on Two Cases
por: Lhotta, Karl, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pd0sanfd2heguj55qob5et8nkc